Additionally, our study provides mechanistic insights into SETD7-dependent epigenetic regulation in ESCC, confirming the regulatory role of the SETD7-H3K4me1-ALDH1A3 axis in modulating ferroptosis sensitivity, which provides a molecular basis for developing targeted therapies against ESCC. This evidence concerns the gene SETD7 and esophageal squamous cell carcinoma.